Expression of miR-223 in neutrophils inhibits the NLRP3/IL-1β axis, reduces airway inflammation, and reduces NLRP3 (Nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain-containing 3) levels and IL-1β release (141). Here, NLRP3 is linked to inflammation.